Table 3 Self-report individual and mean scores of PCBD, MDD, PTSD, and mindfulness before and after treatment and interview-based prevalence rates for the completers (n = 9)

 PCBD scores

Pre-treatment

26

19

22

17

33

32

38

55

25

29.67 (11.70)

–

T1

13*

21

19

21

19*

27

38

47

25

25.56 (10.62)

0.35

FU1

6*

26

11

25

23

16*

37

55

16

23.89 (14.82)

0.41

FU2

7*

19

11

23

19*

22

35

51

11*

22.00 (13.67)

0.57

 MDD scores

Pre-treatment

40

36

37

12

44

28

22

48

12

31.00 (13.29)

–

T1

19*

24

18*

22

25*

24

15

29*

8

20.47 (6.26)

0.97

FU1

5*

28

16*

17

17*

11*

26

32*

11

18.11 (8.89)

1.09

FU2

12*

26

13*

28*

19*

19

18

28*

5

18.74 (7.79)

1.07

 PTSD scores

Pre-treatment

33

22

32

15

58

52

21

55

12

33.33 (17.68)

–

T1

18*

21

23

14

30*

26*

17

45

9

22.56 (10.50)

0.71

FU1

15*

17

12*

22

17*

10*

31

46

4

19.33 (12.55)

0.87

FU2

5*

18

11*

39*

23*

17*

24

42*

2

20.11 (13.75)

0.80

 Mindfulness scores

Pre-treatment

43

59

25

23

48

63

46

53

43

44.78 (13.63)

–

T1

34

50

57*

48*

48

58

25*

57

38

46.11 (11.50)

− 0.10

FU1

32

61

29

37

48

51

51

56

26

43.44 (12.68)

0.10

FU2

4*

51

26

43*

47

56

43

54

18*

38.00 (17.96)

0.41

% met criteria

 PCBD diagnosis

Pre-treatment

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

100

–

Post-treatment

No

No

No

No

Yes

No

Yes

Yes

Yes

44.4

–

 MDD diagnosis

Pre-treatment

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

100

–

Post-treatment

No

Yes

No

No

Yes

No

Yes

No

No

33.3

–

 PTSD diagnosis

Pre-treatment

Yes

No

No

No

Yes

Yes

No

Yes

Yes

55.6

–

Post-treatment

No

No

No

No

Yes

No

No

No

No

11.1

–

 Extent of hope

Pre-treatment

1

8

2

8

5

1

10

10

10

–

–

Post-treatment

1

5

1

5

5

1

9

10

8

–

–